Full-Time
Sales Representative – Biopharma
Prism Biotech
Prelaunch prescriber profiling and targeting
Compensation Overview
$85.3k - $116.5k/yr
Laguna Niguel, CA, USA
In Person
Bachelor's
 Sales & Account Management (1) |
|---|
Get referred to Prism Biotech
See people who can refer or advise you
- Documented sales experience if a relevant degree is not held.
- Ability to quickly build meaningful relationships.
- Ability to thrive and adapt in ambiguous pharmaceutical sales environments.
- Strong clinical selling and account management skills.
- Strong verbal and written communication skills.
- Ability to work and lead collaboratively while prioritizing integrity.
- Uphold and model competencies including integrity, drive, accountability, flexibility, and perseverance.
- Meet or exceed assigned territory pharmaceutical sales goals.
- Use analytical and business acumen skills to identify opportunities and provide actionable recommendations and solutions to increase product growth.
- Maximize new business opportunities and develop and grow the pharmaceutical market.
- Communicate competitive market intelligence to brand teams and management.
- Collaborate cross-functionally with Division Business Managers, Regional Business Directors, and corporate commercial teams.
- Comply with corporate and pharmaceutical sales legal requirements for product promotion, sampling, and resource tracking.
- Develop local Opinion Leader relationships to achieve aligned objectives.
- A relevant degree.
- Specialty pharmaceutical sales experience.
Prism Biotech provides field sales and medical affairs services to support pharmaceutical launches. It deploys pharmaceutical sales reps and medical science liaisons before product approval to collect prescriber information through office visits. The data gathered is combined with existing records to create a profile of key prescriber targets and disease states. This profiling happens before a launch so the sales team is prepared with identified targets and relevant physician insights. Prism Biotech differentiates itself by offering a full-service prelaunch target physician profiling workflow, aligning early market intelligence with product planning. The company’s goal is to prime and ready the sales force with accurate, ready-to-target physician profiles ahead of a brand’s approval and launch.
Company Size
N/A
Company Stage
N/A
Total Funding
N/A
Headquarters
Upper Merion Township, Pennsylvania
Founded
2019
Get referred to Prism Biotech
See people who can refer or advise you
Simplify's Take
What believers are saying
- Ono paid an initial milestone in November 2025, proving partner monetization.
- Receptor.AI partnership on March 12, 2026 expands PRISM into AI-guided discovery.
- Eisai presented E7386 preclinical and Phase 1 results in 2026, strengthening credibility.
What critics are saying
- Servier terminated its collaboration and licensing agreement with PRISM BioLab in 2026.
- Boehringer Ingelheim agreement expired in 2026, shrinking partnered revenue optionality.
- PRISM depends on external partnerships; a pipeline failure would crush Japan-listed growth equity valuation.
What makes Prism Biotech unique
- PepMetics® targets intracellular PPIs and membrane proteins using orally available small molecules.
- Eisai and PRISM co-created E7386, validating PRISM’s chemistry in oncology.
- PRISM licenses platform discovery across pharma partners, not just single in-house programs.
Help us improve and share your feedback! Did you find this helpful?